These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27377417)

  • 1. Psychiatric disorders biochemical pathways unraveled by human brain proteomics.
    Saia-Cereda VM; Cassoli JS; Martins-de-Souza D; Nascimento JM
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):3-17. PubMed ID: 27377417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and psychiatric disorders.
    Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
    Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.
    Zuccoli GS; Saia-Cereda VM; Nascimento JM; Martins-de-Souza D
    Front Neurosci; 2017; 11():493. PubMed ID: 28936160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology.
    Schubert KO; Föcking M; Cotter DR
    Schizophr Res; 2015 Sep; 167(1-3):64-72. PubMed ID: 25728835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.
    Wesseling H; Guest PC; Lago SG; Bahn S
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1327-41. PubMed ID: 24524332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.
    Saia-Cereda VM; Cassoli JS; Schmitt A; Falkai P; Nascimento JM; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):601-12. PubMed ID: 26232077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.
    Andreazza AC
    Mol Biosyst; 2012 Oct; 8(10):2503-12. PubMed ID: 22710408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder.
    Föcking M; Dicker P; Lopez LM; Hryniewiecka M; Wynne K; English JA; Cagney G; Cotter DR
    Transl Psychiatry; 2016 Nov; 6(11):e959. PubMed ID: 27898073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic, and Environmental Factors.
    Iwata K
    Methods Mol Biol; 2019; 1916():41-48. PubMed ID: 30535680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic investigation in psychiatric disorders.
    Yao JK; Reddy RD
    Mol Neurobiol; 2005; 31(1-3):193-203. PubMed ID: 15953821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-driven progress in neurodegeneration research.
    Fountoulakis M; Kossida S
    Electrophoresis; 2006 Apr; 27(8):1556-73. PubMed ID: 16555340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of biomarkers in psychiatry: focus on proteomics.
    Sokolowska I; Ngounou Wetie AG; Wormwood K; Thome J; Darie CC; Woods AG
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S9-18. PubMed ID: 24357051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Studies of Psychiatric Disorders.
    Guest PC
    Methods Mol Biol; 2018; 1735():59-89. PubMed ID: 29380307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmortem human brain genomics in neuropsychiatric disorders--how far can we go?
    Jaffe AE
    Curr Opin Neurobiol; 2016 Feb; 36():107-11. PubMed ID: 26685806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: an update.
    Bennett CN; Horrobin DF
    Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):47-59. PubMed ID: 10970713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress and signaling pathways regulating autophagy: From behavioral models to psychiatric disorders.
    Pierone BC; Pereira CA; Garcez ML; Kaster MP
    Exp Neurol; 2020 Dec; 334():113485. PubMed ID: 32987001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroproteomics of schizophrenia.
    English JA; Pennington K; Dunn MJ; Cotter DR
    Biol Psychiatry; 2011 Jan; 69(2):163-72. PubMed ID: 20887976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteomics: biomarker research in psychiatry].
    Hünnerkopf R; Grassl J; Thome J
    Fortschr Neurol Psychiatr; 2007 Oct; 75(10):579-86. PubMed ID: 17566964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and psychiatric disorders.
    Jou SH; Chiu NY; Liu CS
    Chang Gung Med J; 2009; 32(4):370-9. PubMed ID: 19664343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.